Gilead says remdesivir coronavirus treatment reduces risk of death in severely sick patients
Source: CNBC Gilead Sciences announced new findings Friday that its antiviral drug remdesivir reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone. […]